Canaccord Adams' Life Sciences Group serves clients across all sectors of healthcare, including biotechnology & pharmaceuticals medical devices, healthcare services and healthcare information technology. Our Life Sciences Group has extensive industry wide relationships and is among the largest dedicated industry groups in the U.S. Canaccord Adams has over 75 investment bankers strategically located across the country, as well as in Canada and the U.K., in many of the industry's key cities. Our senior members of the Life Sciences Group have years of healthcare investment banking experience and strategic insight to their clients in the ever changing reimbursement, regulatory and technological environment characteristic of the industry.

Canaccord Adams's Life Sciences Group focuses on public and private healthcare companies, at all stages of development, providing them creative growth-oriented strategic and financial solutions, including private and public debt and equity transactions as well as mergers and acquisitions. Canaccord Adam's Life Sciences Group has been extremely active, having executed on over 100 transactions in the last two years, valued at over $3 billion.

Please click here to view our Recent Transactions.    
 
Please click here to view our Historical Transactions.

Senior Team